Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study
Identifieur interne : 004E32 ( Main/Exploration ); précédent : 004E31; suivant : 004E33Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study
Auteurs : A. Wirth [Australie] ; M. Gospodarowicz [Canada] ; B. M. P. Aleman [Pays-Bas] ; M. Bressel [Australie] ; A. Ng [États-Unis] ; M. Chao [Australie] ; R. T. Hoppe [États-Unis] ; C. Thieblemont [France] ; R. Tsang [Canada] ; L. Moser [Allemagne] ; L. Specht [Danemark] ; T. Szpytma [Pologne] ; A. Lennard [Royaume-Uni] ; J. F. Seymour [Australie] ; E. Zucca [Suisse]Source :
- Annals of oncology [ 0923-7534 ] ; 2013.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Background: We evaluated the long-term results of radiotherapy for patients with gastric marginal zone lymphoma (GMZL). Patients and methods: We carried out a retrospective, multi-centre study of patients with low-grade GMZL treated by radiotherapy between 17 July 1981 and 25 March 2004. Results: There were 102 eligible patients. Fifty-eight patients were previously untreated and 44 had recurrent/residual disease after prior treatment (HP eradication, chemotherapy and surgery in 35, 9 and 8 patients, respectively, and 7 had >1 prior therapy). Radiation fields included the stomach /involved nodes in 61 patients and whole abdomen in 41. The median radiotherapy dose to stomach was 40 Gy (range 26-46 Gy) in a median 22 fractions. With a median follow-up after radiotherapy of 7.9 years (range 0.3-24 years), 10- and 15-year freedom from treatment failure (FFTF) was 88% (95% CI 82%-95%). Risk factors for TF were a large-cell component (P = 0.036) and an exophytic growth pattern (P = 0.042). Radiotherapy field size, radiotherapy dose, and failure of prior therapy were not associated with inferior FFTF. Ten-year overall survival was 70% (95% CI 60%-82%). Conclusions: Radiotherapy achieves cure for the majority of patients with low-grade GMZL, including patients who have had prior therapy. Several features may predict a poorer outcome.
Affiliations:
- Allemagne, Australie, Canada, Danemark, France, Pays-Bas, Pologne, Royaume-Uni, Suisse, États-Unis
- Berlin, Hollande-Septentrionale, Hovedstaden, Massachusetts, Victoria (État), Île-de-France
- Amsterdam, Berlin, Boston, Copenhague, Melbourne, Paris
- Université de Melbourne
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000A69
- to stream PascalFrancis, to step Curation: 005402
- to stream PascalFrancis, to step Checkpoint: 000825
- to stream Main, to step Merge: 004F99
- to stream Main, to step Curation: 004E32
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study</title><author><name sortKey="Wirth, A" sort="Wirth, A" uniqKey="Wirth A" first="A." last="Wirth">A. Wirth</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne</s1><s2>Parkville, Victoria</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Gospodarowicz, M" sort="Gospodarowicz, M" uniqKey="Gospodarowicz M" first="M." last="Gospodarowicz">M. Gospodarowicz</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Radiation Medicine Program, Princess Margaret Cancer Centre</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>2 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Aleman, B M P" sort="Aleman, B M P" uniqKey="Aleman B" first="B. M. P." last="Aleman">B. M. P. Aleman</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Radiation Oncology, The Netherlands Cancer Institute</s1><s2>Amsterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bressel, M" sort="Bressel, M" uniqKey="Bressel M" first="M." last="Bressel">M. Bressel</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Statistics and Clinical Trials, Peter MacCallum Cancer Centre</s1><s2>East Melbourne</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>East Melbourne</wicri:noRegion></affiliation></author><author><name sortKey="Ng, A" sort="Ng, A" uniqKey="Ng A" first="A." last="Ng">A. Ng</name><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>Department of Radiation Oncology, Brigham and Women's Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Chao, M" sort="Chao, M" uniqKey="Chao M" first="M." last="Chao">M. Chao</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Radiation Oncology Victoria, East Melbourne</s1><s2>Victoria</s2><s3>AUS</s3><sZ>6 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Hoppe, R T" sort="Hoppe, R T" uniqKey="Hoppe R" first="R. T." last="Hoppe">R. T. Hoppe</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Radiation Oncology, Stanford University</s1><s2>Stanford</s2><s3>USA</s3><sZ>7 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Stanford</wicri:noRegion></affiliation></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name><affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Hemato-oncology, Hopital Saint-Louis</s1><s2>Paris</s2><s3>FRA</s3><sZ>8 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tsang, R" sort="Tsang, R" uniqKey="Tsang R" first="R." last="Tsang">R. Tsang</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Radiation Medicine Program, Princess Margaret Cancer Centre</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>2 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Moser, L" sort="Moser, L" uniqKey="Moser L" first="L." last="Moser">L. Moser</name><affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Klinik fur Radioonkologie und Strahlentherapie, Charité-Universitätsmedizin Berlin Campus Benjamin Franklin</s1><s2>Berlin</s2><s3>DEU</s3><sZ>10 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Specht, L" sort="Specht, L" uniqKey="Specht L" first="L." last="Specht">L. Specht</name><affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Department of Oncology and Haematology, The Finsen Centre, Copenhagen University Hospital (Rigshospitalet)</s1><s2>Copenhagen</s2><s3>DNK</s3><sZ>11 aut.</sZ></inist:fA14><country>Danemark</country><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Szpytma, T" sort="Szpytma, T" uniqKey="Szpytma T" first="T." last="Szpytma">T. Szpytma</name><affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Centrum Onkologii-Inst. Im. M. Sklodowskiej-Curie</s1><s2>Krakow</s2><s3>POL</s3><sZ>12 aut.</sZ></inist:fA14><country>Pologne</country><wicri:noRegion>Centrum Onkologii-Inst. Im. M. Sklodowskiej-Curie</wicri:noRegion></affiliation></author><author><name sortKey="Lennard, A" sort="Lennard, A" uniqKey="Lennard A" first="A." last="Lennard">A. Lennard</name><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Freeman Hospital, High Heaton</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>13 aut.</sZ></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name><affiliation wicri:level="4"><inist:fA14 i1="13"><s1>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne</s1><s2>Parkville, Victoria</s2><s3>AUS</s3><sZ>14 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Oncology Institute of Southern Switzerland, Ospedale San Giovanni</s1><s2>Bellinzona</s2><s3>CHE</s3><sZ>15 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>Bellinzona</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">13-0178595</idno><date when="2013">2013</date><idno type="stanalyst">PASCAL 13-0178595 INIST</idno><idno type="RBID">Pascal:13-0178595</idno><idno type="wicri:Area/PascalFrancis/Corpus">000A69</idno><idno type="wicri:Area/PascalFrancis/Curation">005402</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000825</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000825</idno><idno type="wicri:doubleKey">0923-7534:2013:Wirth A:long:term:outcome</idno><idno type="wicri:Area/Main/Merge">004F99</idno><idno type="wicri:Area/Main/Curation">004E32</idno><idno type="wicri:Area/Main/Exploration">004E32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study</title><author><name sortKey="Wirth, A" sort="Wirth, A" uniqKey="Wirth A" first="A." last="Wirth">A. Wirth</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne</s1><s2>Parkville, Victoria</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Gospodarowicz, M" sort="Gospodarowicz, M" uniqKey="Gospodarowicz M" first="M." last="Gospodarowicz">M. Gospodarowicz</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Radiation Medicine Program, Princess Margaret Cancer Centre</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>2 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Aleman, B M P" sort="Aleman, B M P" uniqKey="Aleman B" first="B. M. P." last="Aleman">B. M. P. Aleman</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Radiation Oncology, The Netherlands Cancer Institute</s1><s2>Amsterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bressel, M" sort="Bressel, M" uniqKey="Bressel M" first="M." last="Bressel">M. Bressel</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Statistics and Clinical Trials, Peter MacCallum Cancer Centre</s1><s2>East Melbourne</s2><s3>AUS</s3><sZ>4 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>East Melbourne</wicri:noRegion></affiliation></author><author><name sortKey="Ng, A" sort="Ng, A" uniqKey="Ng A" first="A." last="Ng">A. Ng</name><affiliation wicri:level="3"><inist:fA14 i1="05"><s1>Department of Radiation Oncology, Brigham and Women's Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Chao, M" sort="Chao, M" uniqKey="Chao M" first="M." last="Chao">M. Chao</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Radiation Oncology Victoria, East Melbourne</s1><s2>Victoria</s2><s3>AUS</s3><sZ>6 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Hoppe, R T" sort="Hoppe, R T" uniqKey="Hoppe R" first="R. T." last="Hoppe">R. T. Hoppe</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Radiation Oncology, Stanford University</s1><s2>Stanford</s2><s3>USA</s3><sZ>7 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Stanford</wicri:noRegion></affiliation></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name><affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Hemato-oncology, Hopital Saint-Louis</s1><s2>Paris</s2><s3>FRA</s3><sZ>8 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tsang, R" sort="Tsang, R" uniqKey="Tsang R" first="R." last="Tsang">R. Tsang</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Radiation Medicine Program, Princess Margaret Cancer Centre</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>2 aut.</sZ><sZ>9 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Moser, L" sort="Moser, L" uniqKey="Moser L" first="L." last="Moser">L. Moser</name><affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Klinik fur Radioonkologie und Strahlentherapie, Charité-Universitätsmedizin Berlin Campus Benjamin Franklin</s1><s2>Berlin</s2><s3>DEU</s3><sZ>10 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Specht, L" sort="Specht, L" uniqKey="Specht L" first="L." last="Specht">L. Specht</name><affiliation wicri:level="3"><inist:fA14 i1="10"><s1>Department of Oncology and Haematology, The Finsen Centre, Copenhagen University Hospital (Rigshospitalet)</s1><s2>Copenhagen</s2><s3>DNK</s3><sZ>11 aut.</sZ></inist:fA14><country>Danemark</country><placeName><settlement type="city">Copenhague</settlement><region type="région" nuts="2">Hovedstaden</region></placeName></affiliation></author><author><name sortKey="Szpytma, T" sort="Szpytma, T" uniqKey="Szpytma T" first="T." last="Szpytma">T. Szpytma</name><affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Centrum Onkologii-Inst. Im. M. Sklodowskiej-Curie</s1><s2>Krakow</s2><s3>POL</s3><sZ>12 aut.</sZ></inist:fA14><country>Pologne</country><wicri:noRegion>Centrum Onkologii-Inst. Im. M. Sklodowskiej-Curie</wicri:noRegion></affiliation></author><author><name sortKey="Lennard, A" sort="Lennard, A" uniqKey="Lennard A" first="A." last="Lennard">A. Lennard</name><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Freeman Hospital, High Heaton</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>13 aut.</sZ></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name><affiliation wicri:level="4"><inist:fA14 i1="13"><s1>Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne</s1><s2>Parkville, Victoria</s2><s3>AUS</s3><sZ>14 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Oncology Institute of Southern Switzerland, Ospedale San Giovanni</s1><s2>Bellinzona</s2><s3>CHE</s3><sZ>15 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>Bellinzona</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Annals of oncology</title><title level="j" type="abbreviated">Ann. oncol.</title><idno type="ISSN">0923-7534</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Annals of oncology</title><title level="j" type="abbreviated">Ann. oncol.</title><idno type="ISSN">0923-7534</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chronic</term><term>Extraganglionar</term><term>International</term><term>Long term</term><term>Lymph node</term><term>Lymphoid neoplasm</term><term>Marginal zone</term><term>Marginal zone lymphoma</term><term>Prognosis</term><term>Radiotherapy</term><term>Retrospective</term><term>Stomach</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Long terme</term><term>Pronostic</term><term>Estomac</term><term>Lymphome de la zone marginale</term><term>Traitement</term><term>Radiothérapie</term><term>Rétrospective</term><term>International</term><term>Ganglion lymphatique</term><term>Extraganglionnaire</term><term>Chronique</term><term>Hémopathie maligne lymphoïde</term><term>Zone marginale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: We evaluated the long-term results of radiotherapy for patients with gastric marginal zone lymphoma (GMZL). Patients and methods: We carried out a retrospective, multi-centre study of patients with low-grade GMZL treated by radiotherapy between 17 July 1981 and 25 March 2004. Results: There were 102 eligible patients. Fifty-eight patients were previously untreated and 44 had recurrent/residual disease after prior treatment (HP eradication, chemotherapy and surgery in 35, 9 and 8 patients, respectively, and 7 had >1 prior therapy). Radiation fields included the stomach /involved nodes in 61 patients and whole abdomen in 41. The median radiotherapy dose to stomach was 40 Gy (range 26-46 Gy) in a median 22 fractions. With a median follow-up after radiotherapy of 7.9 years (range 0.3-24 years), 10- and 15-year freedom from treatment failure (FFTF) was 88% (95% CI 82%-95%). Risk factors for TF were a large-cell component (P = 0.036) and an exophytic growth pattern (P = 0.042). Radiotherapy field size, radiotherapy dose, and failure of prior therapy were not associated with inferior FFTF. Ten-year overall survival was 70% (95% CI 60%-82%). Conclusions: Radiotherapy achieves cure for the majority of patients with low-grade GMZL, including patients who have had prior therapy. Several features may predict a poorer outcome.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Canada</li><li>Danemark</li><li>France</li><li>Pays-Bas</li><li>Pologne</li><li>Royaume-Uni</li><li>Suisse</li><li>États-Unis</li></country><region><li>Berlin</li><li>Hollande-Septentrionale</li><li>Hovedstaden</li><li>Massachusetts</li><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Amsterdam</li><li>Berlin</li><li>Boston</li><li>Copenhague</li><li>Melbourne</li><li>Paris</li></settlement><orgName><li>Université de Melbourne</li></orgName></list><tree><country name="Australie"><region name="Victoria (État)"><name sortKey="Wirth, A" sort="Wirth, A" uniqKey="Wirth A" first="A." last="Wirth">A. Wirth</name></region><name sortKey="Bressel, M" sort="Bressel, M" uniqKey="Bressel M" first="M." last="Bressel">M. Bressel</name><name sortKey="Chao, M" sort="Chao, M" uniqKey="Chao M" first="M." last="Chao">M. Chao</name><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name></country><country name="Canada"><noRegion><name sortKey="Gospodarowicz, M" sort="Gospodarowicz, M" uniqKey="Gospodarowicz M" first="M." last="Gospodarowicz">M. Gospodarowicz</name></noRegion><name sortKey="Tsang, R" sort="Tsang, R" uniqKey="Tsang R" first="R." last="Tsang">R. Tsang</name></country><country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Aleman, B M P" sort="Aleman, B M P" uniqKey="Aleman B" first="B. M. P." last="Aleman">B. M. P. Aleman</name></region></country><country name="États-Unis"><region name="Massachusetts"><name sortKey="Ng, A" sort="Ng, A" uniqKey="Ng A" first="A." last="Ng">A. Ng</name></region><name sortKey="Hoppe, R T" sort="Hoppe, R T" uniqKey="Hoppe R" first="R. T." last="Hoppe">R. T. Hoppe</name></country><country name="France"><region name="Île-de-France"><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name></region></country><country name="Allemagne"><region name="Berlin"><name sortKey="Moser, L" sort="Moser, L" uniqKey="Moser L" first="L." last="Moser">L. Moser</name></region></country><country name="Danemark"><region name="Hovedstaden"><name sortKey="Specht, L" sort="Specht, L" uniqKey="Specht L" first="L." last="Specht">L. Specht</name></region></country><country name="Pologne"><noRegion><name sortKey="Szpytma, T" sort="Szpytma, T" uniqKey="Szpytma T" first="T." last="Szpytma">T. Szpytma</name></noRegion></country><country name="Royaume-Uni"><noRegion><name sortKey="Lennard, A" sort="Lennard, A" uniqKey="Lennard A" first="A." last="Lennard">A. Lennard</name></noRegion></country><country name="Suisse"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:13-0178595
|texte= Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study
}}
| This area was generated with Dilib version V0.6.33. |  |